[Mitochondrial myopathy, deafness and type 2 diabetes mellitus with tRNALeu(UUR) point mutation in mitochondrial DNA]. 1998

L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
Klinika dĕtského a dorostového lékarství 1. LF UK a VFN, Praha.

BACKGROUND A heteroplasmic A3243G point mutation in tRNALeu(UUR) gene of mitochondrial DNA (mtDNA) is found in patients with MELAS syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes), less frequently in patients with other dominating clinical features, such as deafness, diabetes mellitus type 2, hypertrophic cardiomyopathy, renal problems or inborn development defects. Present report describes histochemical, enzymatic and molecular biology studies of the family with clinical variant of meals syndrome. RESULTS A 45-year-old woman with progressive muscle weakness, external ophtalmoplegia, perceptive deafness, ischemic heart disease, diabetes mellitus type 2 and hyperlactacidemia was metabolically investigated because the multiorgan problems indicated mitochondrial origin of the disease. Muscle biopsy revealed pronounced myopathic changes, ragged red fibers and decreased activity of respiratory chain enzymes - succinate cytochrome c reductase (< 5% control) and cytochrome c oxidase (< 10% control). Restriction fragment analysis of mtDNA from muscle, blood and hair follicles detected heteroplasmic A -> G mutation in the position 3243 of the tRNALeu(UUR) gene, which was more pronounced in muscle (28% of total mtDNA) than in blood (12%) or in hair follicles (10%). No mutation was found in blood and hair follicles of patient's mother and daughter. CONCLUSIONS Diagnostics of mitochondrial diseases require close collaboration of clinicians with specialised laboratories. Treatment of mitochondrial disorders is only symptomatic, however, early diagnosis of the molecular defect is important for genetic counselling.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003638 Deafness A general term for the complete loss of the ability to hear from both ears. Deafness Permanent,Hearing Loss Permanent,Prelingual Deafness,Deaf Mutism,Deaf-Mutism,Deafness, Acquired,Hearing Loss, Complete,Hearing Loss, Extreme,Acquired Deafness,Complete Hearing Loss,Deafness, Prelingual,Extreme Hearing Loss,Permanent, Deafness,Permanent, Hearing Loss,Permanents, Deafness
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004272 DNA, Mitochondrial Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. Mitochondrial DNA,mtDNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017240 Mitochondrial Myopathies A group of muscle diseases associated with abnormal mitochondria function. Myopathies, Mitochondrial,Luft Disease,Luft's Disease,Megaconial Myopathies,Mitochondrial Myopathy,Pleoconial Myopathies,Disease, Luft,Disease, Luft's,Lufts Disease,Megaconial Myopathy,Myopathies, Pleoconial,Myopathy, Megaconial,Myopathy, Pleoconial,Pleoconial Myopathy
D017241 MELAS Syndrome A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. (From Joynt, Clinical Neurology, 1992, Ch56, p117) Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode,MELAS,Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes,Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes,Myopathy, Mitochondrial-Encephalopathy-Lactic Acidosis-Stroke,Syndrome, MELAS
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations

Related Publications

L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
July 1995, Diabetes care,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
April 1993, FEBS letters,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
March 1998, Internal medicine (Tokyo, Japan),
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
July 1996, Diabetes care,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
April 2004, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
July 2003, Yi chuan = Hereditas,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
June 2003, Diabetes care,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
June 1995, Diabetes care,
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
May 1993, Lancet (London, England),
L Stratilová, and J Zeman, and H Hansíková, and J Houstĕk, and J Hermanská, and Z Dudková, and V Konrádová, and H Hůlková, and M Elleder
February 2009, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
Copied contents to your clipboard!